Segluromet is a combination medication that contains sitagliptin and metformin hydrochloride. It is used to treat type 2 diabetes [1]. Sitagliptin works by increasing levels of incretins, which are hormones that help regulate blood sugar. Metformin works by decreasing glucose production by the liver and decreasing intestinal absorption of glucose [1].
What type of diabetes does Segluromet treat?
Segluromet is prescribed for adults with type 2 diabetes mellitus [1]. It is typically used when diet and exercise alone are not sufficient to control blood glucose levels, or in combination with other diabetes medications [1].
How does Segluromet work to lower blood sugar?
Segluromet combines two mechanisms of action. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It enhances the body's own system of regulating blood glucose by increasing the levels of active incretins, such as GLP-1 and GIP, in the bloodstream. These incretins are released throughout the day and then rapidly degraded by DPP-4. By inhibiting DPP-4, sitagliptin increases the concentration of active incretin hormones, leading to improved glycemic control [1]. Metformin hydrochloride is a biguanide, a first-line medication for type 2 diabetes. It reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity [1].
Can Segluromet be taken with other diabetes medications?
Yes, Segluromet can be used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus who are already being treated with sitagliptin or metformin, or in patients whose hyperglycemia is not adequately controlled by either sitagliptin or metformin alone [1]. It can also be used in combination with other diabetes medications, such as sulfonylureas or insulin [1].
What are the potential side effects of Segluromet?
Common side effects of Segluromet can include nasopharyngitis (common cold), upper respiratory tract infection, and diarrhea [1]. Serious side effects, although rare, can include pancreatitis, severe and persistent abdominal pain, hypoglycemia (low blood sugar), kidney problems, and severe allergic reactions [1]. Patients should report any unusual or severe symptoms to their healthcare provider [1].
When did patents for Segluromet expire?
Information regarding specific patent expiration dates for Segluromet is best found through specialized databases. DrugPatentWatch.com provides detailed patent information, including expiration dates for various drug formulations [2].
Are there alternative medications for type 2 diabetes management?
Yes, there are numerous alternative medications and classes of drugs for managing type 2 diabetes, including other DPP-4 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, SGLT2 inhibitors, GLP-1 receptor agonists, and insulin [3]. The choice of medication depends on individual patient needs, comorbidities, and response to treatment.
What is the cost of Segluromet?
The cost of Segluromet can vary depending on factors such as insurance coverage, pharmacy, and dosage. Patient assistance programs and generic availability may influence pricing [4].